ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

2.97
-1.06
(-26.30%)
Closed June 19 4:00PM
2.86
-0.11
(-3.70%)
After Hours: 7:58PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.86
Bid
2.85
Ask
2.95
Volume
9,402,862
2.44 Day's Range 3.82
0.50 52 Week Range 4.32
Market Cap
Previous Close
4.03
Open
3.78
Last Trade
58
@
2.86
Last Trade Time
Financial Volume
$ 27,794,171
VWAP
2.9559
Average Volume (3m)
2,024,533
Shares Outstanding
186,960,193
Dividend Yield
-
PE Ratio
-4.99
Earnings Per Share (EPS)
-0.6
Revenue
15.45M
Net Profit
-111.57M

About Taysha Gene Therapies Inc

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and com... Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Dover, Delaware, USA
Founded
1970
Taysha Gene Therapies Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSHA. The last closing price for Taysha Gene Therapies was $4.03. Over the last year, Taysha Gene Therapies shares have traded in a share price range of $ 0.50 to $ 4.32.

Taysha Gene Therapies currently has 186,960,193 shares outstanding. The market capitalization of Taysha Gene Therapies is $557.14 million. Taysha Gene Therapies has a price to earnings ratio (PE ratio) of -4.99.

TSHA Latest News

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and an encouraging...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, June 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene...

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

Completed dosing in cohort one (low dose, 5.7x1014 total vg) of REVEAL Phase 1/2 adolescent and adult trial with longer-term data supporting the safety profile and durable response of TSHA-102;...

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

TSHA Discussion

View Posts
LegendaryNomad22 LegendaryNomad22 13 hours ago
Weird. Both TSHA and NGNE have gene therapy candidates for Rett and both of them tanked today, despite sharing strong interim results. There's an International Rett Syndrome Foundation meeting today and tomorrow, so I wonder if something happened there to take the wind out of the gene therapy treatment class. Anyone have any knowledge here?
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 18 hours ago
Diluted on news
πŸ‘οΈ0
Pip611 Pip611 18 hours ago
Ouch - what happen?
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 23 hours ago
TSHA...GAPPING
πŸ‘οΈ0
Tiger Money Tiger Money 6 days ago
Yes, no sorry, didn’t mean to imply that. I was asking if you have other bio names you have on your radar (obviously know about this and Huma). Thanks
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 days ago
chart has nothing to do with what sector!!
πŸ‘οΈ0
Tiger Money Tiger Money 6 days ago
You have the bios nailed down! Any I should put on my radar? As always, thank you as I sincerely appreciate your help and knowledge. Thanks!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 days ago
TSHA BREAK OUT
πŸ‘οΈ0
Monksdream Monksdream 2 weeks ago
TSHA new 52 week high
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 weeks ago
TSHA...HERES 4 DOLLA
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 weeks ago
TSHA...READY FOR 4
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 weeks ago
TSHA...BIO BEAST BREAKING HEWRE CHAINS
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 weeks ago
TSHA HERE WE GO ON THE BREAK OUT!!
πŸ‘οΈ0
glenn1919 glenn1919 3 weeks ago
TSHA......................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 3 weeks ago
TSHA HERE COMES THE BREAK
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 3 weeks ago
TSHA...NEXT BIO READY TO BEAST!
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 3 weeks ago
Taysha may have the real ONE-SHOT genetic cure. It may REALLY work.
Good luck getting any health insurance plan to list this $Million dollar shot in their drug formulary.
πŸ‘οΈ0
Monksdream Monksdream 4 weeks ago
TSHA under $5
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
TSHA..............................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 3 months ago
TSHA..READY TO PUSH TO 4.00
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 3 months ago
TSHA...MONSTER
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 3 months ago
TSHA...HERE WE GO
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
TSHA..here we go
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
TSHA...MONSTER
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 4 months ago
TSHA NEXT BIO BEAST TO RUN TO 3.61 WATCH THE MAGIC
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 5 months ago
β€œDosing the first pediatric patient with Rett syndrome marks an important step forward in our efforts to broaden the clinical evaluation of TSHA-102 to younger patients with earlier stages of Rett syndrome. We are pleased with our progress on expanding the study of TSHA-102 across a broad population of ages and stages of Rett syndrome to bring a potentially transformative treatment option to all patients and families suffering from this devastating disease,” said Sukumar Nagendran, M.D., President, and Head of R&D of Taysha. β€œThe pediatric trial will build on our ongoing REVEAL adolescent and adult trial, where early data demonstrated improvements across multiple clinical domains in adult patients with the most advanced stage of disease. We also plan to expand our U.S. pediatric trial into the U.K. following the recent acceptance of our CTA by the MHRA.”
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 6 months ago
Estimated Enrollment : 18 participants
(was 12).
https://classic.clinicaltrials.gov/ct2/show/NCT05606614
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 6 months ago
β€œFollowing review of the initial clinical data from the first two adult patients treated with TSHA-102 and Chemistry, Manufacturing, and Controls (CMC) data, Health Canada has authorized our protocol amendment to include adolescent patients aged 12 years and older in the ongoing REVEAL Phase 1/2 adult trial,”
https://ih.advfn.com/stock-market/NASDAQ/taysha-gene-therapies-TSHA/stock-news/92678004/taysha-gene-therapies-announces-expanded-eligibili
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 7 months ago
The P1 TSHA-102 REVEAL Adult Study has been on a slow boat.
Hopefully, the Clinical Updates PR will give the push to finally complete enrollment of the 12 adult female Rett patients needed for the trial.
I'm guessing reluctance to enroll has been based on the one-time injection into the intrathecal space (directly into the Cerebral Spinal Fluid).
It's definitely worth the risk, IMO. Good Luck to All.
πŸ‘οΈ0
bikaver bikaver 9 months ago
TSHA.....Definitely headed in the right direction now. A couple more days of downward momo would be great.
πŸ‘οΈ0
make it happen make it happen 9 months ago
Cannacord Genuity and Truist Securities both lowered there price targets, never a good thing...
πŸ‘οΈ0
make it happen make it happen 9 months ago
Think it's about there. I believe we flush under $3.00 and don't come back to the this price per share PPS till R/S. A ways away but see it happening. JMHO
πŸ‘οΈ0
bikaver bikaver 9 months ago
TSHA.....kicking my butt.....next week is make or break!
πŸ‘οΈ0
Triple nickle Triple nickle 10 months ago
Good call my .90 are looking ripe
πŸ‘οΈ0
bikaver bikaver 10 months ago
Added 3.28 today.
πŸ‘οΈ0
bikaver bikaver 10 months ago
TSHA.....Today, all day, was a bull trap. Tomorrow could be Free Falling Friday.
πŸ‘οΈ0
bikaver bikaver 10 months ago
TSHA.....The buyers at 2.85-2.91 proves the phrase "There's a sucker born every minute." to be true.
πŸ‘οΈ0
richme richme 10 months ago
Looks like the rocket exploded! Was tempted to buy; glad I did not!

Finally bought 2.19 for 6K shares; too soon; down more now to 2.14.
πŸ‘οΈ0
Jess070283 Jess070283 10 months ago
Blast off at open?
πŸ‘οΈ0
riha riha 10 months ago
at least i don't feel foolish now.

tomorrow though... i might.
πŸ‘οΈ0
alchemytrader alchemytrader 10 months ago
be glad you didnt get any. hit 2.91 a/h.
πŸ‘οΈ0
alchemytrader alchemytrader 10 months ago
2.85 RIP
πŸ‘οΈ0
Triple nickle Triple nickle 10 months ago
Tif function
πŸ‘οΈ0
riha riha 10 months ago
I can't get any shorts... fuck
πŸ‘οΈ0
bikaver bikaver 10 months ago
TSHA..... added 2.10 short into this strong close.
πŸ‘οΈ0
bikaver bikaver 10 months ago
TSHA.....short @ 1.79
πŸ‘οΈ0
snave599 snave599 10 months ago
Because it's up 130%.That's why it's halted.
πŸ‘οΈ0
Romiman Romiman 10 months ago
Halted 2 times already this morning
πŸ‘οΈ0
make it happen make it happen 10 months ago
Hundreds of millions of shares being sold for $0.90 share structure is multiplying time over 3 massive dilution imho
πŸ‘οΈ0
Awl416 Awl416 10 months ago
Taysha Gene Therapies Announces $150 Million Private Placement Financing
πŸ‘οΈ0